Patents by Inventor Audrey C. Papp

Audrey C. Papp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160040239
    Abstract: Methods and compositions for the effect of Cholesteryl ester transfer protein (CETP) polymorphisms on mRNA splicing, statin treatment outcome, response to CETP inhibitor drugs, and myocardial infarction risk are described.
    Type: Application
    Filed: August 6, 2015
    Publication date: February 11, 2016
    Inventors: Wolfgang Sadee, Audrey C. Papp
  • Patent number: 9012143
    Abstract: A method for predicting a subject's risk factors for ACE-related disorders includes detecting the allelic status of one or more polymorphisms in a nucleic acid sample of the subject.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: April 21, 2015
    Assignee: The Ohio State University Research Foundation
    Inventors: Wolfgang Sadee, Andrew D. Johnson, Danxin Wang, Audrey C. Papp
  • Publication number: 20140044668
    Abstract: Methods and compositions for the effect of Cholesteryl ester transfer protein (CETP) polymorphisms on mRNA splicing, statin treatment outcome, response to CETP inhibitor drugs, and myocardial infarction risk are described.
    Type: Application
    Filed: February 15, 2012
    Publication date: February 13, 2014
    Applicant: THE OHIO STATE UNIVERSITY
    Inventors: Wolfgang Sadee, Audrey C. Papp
  • Publication number: 20100167947
    Abstract: A method for predicting a subject's risk factors for ACE-related disorders includes detecting the allelic status of one or more polymorphisms in a nucleic acid sample of the subject.
    Type: Application
    Filed: April 30, 2008
    Publication date: July 1, 2010
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Wolfgang Sadee, Andrew D. Johnson, Danxin Wang, Audrey C. Papp
  • Publication number: 20100143921
    Abstract: A method for predicting a subject's risk factors for dopamine transporter or SLC6A3-related disorders. The method includes detecting the allelic status of one or more polymorphisms in a nucleic acid sample of the subject. The present invention also provides a related kit, comprising an assay for detecting the allelic status of one or more polymorphisms in a nucleic acid sample of a subject.
    Type: Application
    Filed: April 30, 2008
    Publication date: June 10, 2010
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Wolfgang Sadee, Audrey C. Papp, Julia Pinsonneault